BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 125 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.63 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $6,000 | -99.1% | 348 | -99.3% | 0.00% | -100.0% |
| Q4 2021 | $668,000 | -94.6% | 48,241 | -94.4% | 0.00% | -95.8% |
| Q3 2021 | $12,475,000 | +5.6% | 868,137 | +16.2% | 0.02% | +9.1% |
| Q2 2021 | $11,810,000 | +4568.0% | 746,971 | +2898.2% | 0.02% | – |
| Q1 2021 | $253,000 | +25200.0% | 24,914 | +15091.5% | 0.00% | – |
| Q4 2020 | $1,000 | -99.9% | 164 | -100.0% | 0.00% | -100.0% |
| Q3 2019 | $949,000 | -58.8% | 331,172 | -45.6% | 0.00% | -66.7% |
| Q2 2019 | $2,306,000 | -63.7% | 608,316 | -22.0% | 0.01% | -62.5% |
| Q1 2019 | $6,344,000 | +80.2% | 779,406 | +78.7% | 0.02% | +60.0% |
| Q4 2018 | $3,520,000 | +31900.0% | 436,137 | +31481.2% | 0.01% | – |
| Q3 2018 | $11,000 | -97.1% | 1,381 | -98.0% | 0.00% | -100.0% |
| Q2 2017 | $385,000 | -81.8% | 69,320 | -72.5% | 0.00% | -83.3% |
| Q1 2017 | $2,117,000 | +298.7% | 252,060 | +200.7% | 0.01% | +200.0% |
| Q4 2016 | $531,000 | +48.7% | 83,835 | +3.7% | 0.00% | +100.0% |
| Q3 2016 | $357,000 | +20.2% | 80,852 | -22.7% | 0.00% | 0.0% |
| Q2 2016 | $297,000 | +2870.0% | 104,574 | +10357.4% | 0.00% | – |
| Q4 2015 | $10,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 7,637,700 | $77,675,000 | 7.44% |
| Burrage Capital Management LLC | 864,916 | $8,796,000 | 7.13% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,367,670 | $24,079,000 | 3.61% |
| HealthCor Management, L.P. | 4,886,440 | $49,695,000 | 1.76% |
| Ghost Tree Capital, LLC | 500,000 | $5,085,000 | 1.20% |
| Integral Health Asset Management, LLC | 400,000 | $4,068,000 | 1.16% |
| Lisanti Capital Growth, LLC | 472,520 | $4,806,000 | 0.62% |
| Parkman Healthcare Partners LLC | 244,680 | $2,488,000 | 0.58% |
| Baker Brothers Advisors | 12,710,818 | $129,269,000 | 0.56% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,605,380 | $26,497,000 | 0.56% |